KRAS and cancer: KRAS is the most mutated oncogene in cancer [124], with mutations in non-small cell lung cancers (NSCLC) (20-25%) [131], colorectal cancers (30–50%) [132] and pancreatic ductal adenocarcinoma (95%) [133].